CEO – Page 3 – Talk Bio

Actionable Insights Powered by AI

UCB’s Strategic Shift: Bristol Myers ADC Partner’s CEO Takes the Helm

12 months ago talkbio0Tagged Administration occupational activities, CEO, Changing, Drug Industry, Myers, Partner in relationship, strategic shift, therapeutic autologous dendritic cells, UCB

UCB, management changes, CEO, Bristol Myers, ADC partner, strategic shift, pharmaceutical industry.

AstraZeneca CEO Pascal Soriot’s Pay Rise Signals Succession Planning

12 months ago talkbio0Tagged AstraZeneca, CEO, Drug Industry, executive compensation, Pascal Soriot, Succession planning

AstraZeneca, Pascal Soriot, CEO, pay rise, succession planning, pharmaceutical industry, executive compensation.

23andMe Stock Surges as CEO Considers Taking Company Private

1 year ago talkbio0Tagged CEO, Privatization Plans, Science of genetics, Stock Jump

23andMe, Stock Jump, CEO, Privatization Plans, Genetics Company

Clasp Therapeutics Launches with $150M Series A Funding to Develop Next-Generation T Cell Engaging Immunotherapies

1 year ago talkbio0Tagged Ataxia Telangiectasia Mutated Proteins, Catalio Capital Management, cellular targeting, CEO, CLASRP gene, engagers, financing characteristics, HLA Molecule Profiling, Holdings, Personalized Off-the-Shelf Therapies, Robert Ross, T-Lymphocyte, Third Rock

Clasp Therapeutics, $150M Series A Financing, T Cell Engagers, Personalized Off-the-Shelf Therapies, Targeting Mutated Protein Fragments, HLA Molecule Profiling, Novo Holdings/ Third Rock Ventures/ Catalio Capital Management, CEO Robert Ross